Sequoia Financial Advisors LLC lifted its holdings in shares of Haleon plc (NYSE:HLN - Free Report) by 232.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 219,548 shares of the company's stock after acquiring an additional 153,506 shares during the quarter. Sequoia Financial Advisors LLC's holdings in Haleon were worth $1,804,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently made changes to their positions in HLN. Farther Finance Advisors LLC raised its holdings in Haleon by 79.3% in the second quarter. Farther Finance Advisors LLC now owns 2,986 shares of the company's stock worth $25,000 after purchasing an additional 1,321 shares in the last quarter. Washington Trust Advisors Inc. boosted its position in Haleon by 353.3% in the third quarter. Washington Trust Advisors Inc. now owns 2,960 shares of the company's stock worth $25,000 after purchasing an additional 2,307 shares during the last quarter. CoreFirst Bank & Trust purchased a new position in Haleon in the fourth quarter worth about $26,000. Barclays PLC boosted its position in Haleon by 56.4% in the second quarter. Barclays PLC now owns 3,317 shares of the company's stock worth $28,000 after purchasing an additional 1,196 shares during the last quarter. Finally, Resurgent Financial Advisors LLC purchased a new position in Haleon in the fourth quarter worth about $29,000. Institutional investors own 6.67% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Argus reaffirmed a "buy" rating on shares of Haleon in a research report on Tuesday, March 26th.
Read Our Latest Analysis on Haleon
Haleon Price Performance
NYSE:HLN traded down $0.16 during trading hours on Friday, reaching $8.01. The stock had a trading volume of 7,843,945 shares, compared to its average volume of 9,039,422. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.73 and a current ratio of 1.04. Haleon plc has a 52 week low of $7.70 and a 52 week high of $9.05. The company has a 50 day moving average price of $8.32 and a two-hundred day moving average price of $8.29. The stock has a market capitalization of $36.57 billion, a PE ratio of 28.61, a PEG ratio of 2.14 and a beta of 0.29.
Haleon Dividend Announcement
The business also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Stockholders of record on Friday, March 15th will be issued a $0.1064 dividend. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, March 14th. Haleon's dividend payout ratio (DPR) is 75.00%.
About Haleon
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Read More
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
